PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32727432-14	2020	In the subgroup with normal weight, higher serum IGF-1 SDS (p = 0.009) and DHEAS SDS (p = 0.003) affected BA advancement independent of BMI SDS.	Barium	106-108	insulin like growth factor 1	Homo sapiens	49-54	
32855970-7	2020	A nonlinear relationship was observed between the IGF-1 standard deviation score (IGF-1 SDS) and BA-CA before and after GH therapy.	Barium	97-99	insulin like growth factor 1	Homo sapiens	50-55	
32855970-7	2020	A nonlinear relationship was observed between the IGF-1 standard deviation score (IGF-1 SDS) and BA-CA before and after GH therapy.	Barium	97-99	insulin like growth factor 1	Homo sapiens	82-87	
32855970-8	2020	Before GH therapy, there was a significant positive association between the IGF-1 SDS and BA-CA when the IGF-1 level was greater than -2 SDS (beta 0.17, 95% CI 0.08, 027; P < 0.001).	Barium	90-92	insulin like growth factor 1	Homo sapiens	76-81	
32855970-8	2020	Before GH therapy, there was a significant positive association between the IGF-1 SDS and BA-CA when the IGF-1 level was greater than -2 SDS (beta 0.17, 95% CI 0.08, 027; P < 0.001).	Barium	90-92	insulin like growth factor 1	Homo sapiens	105-110	
32855970-10	2020	After GH therapy, there was a significant positive association between the IGF-1 SDS and BA-CA when the IGF-1 level was lower than 2 SDS (beta 0.20, 95% CI 0.12, 028; P < 0.001).	Barium	89-91	insulin like growth factor 1	Homo sapiens	75-80	
32855970-10	2020	After GH therapy, there was a significant positive association between the IGF-1 SDS and BA-CA when the IGF-1 level was lower than 2 SDS (beta 0.20, 95% CI 0.12, 028; P < 0.001).	Barium	89-91	insulin like growth factor 1	Homo sapiens	104-109	
32855970-13	2020	There is a nonlinear relationship between IGF-1 and BA maturation in short children before and after GH treatment.	Barium	52-54	insulin like growth factor 1	Homo sapiens	42-47	
32855970-14	2020	These findings suggest that a low level of IGF-1 may contribute to BA delay in short children and adolescents.	Barium	67-69	insulin like growth factor 1	Homo sapiens	43-48	
32727432-9	2020	The advanced BA group had significantly higher BMI SDS, serum DHEAS SDS, IGF-1 SDS, androstenedione and fasting insulin and significantly lower sex hormone binding globulin (all p < 0.001).	Barium	13-15	insulin like growth factor 1	Homo sapiens	73-78	
32727432-11	2020	In the multiple linear regression model, serum IGF-1 SDS, BMI SDS and DHEAS SDS were the strongest predictors of advanced BA, accounting for 19.3% of the variance.	Barium	122-124	insulin like growth factor 1	Homo sapiens	47-52	
34256051-8	2021	There were differences in IGF-1 values between the CA and BA groups at the age of 10-11 years for boys and 7-11 years for girls.	Barium	58-60	insulin like growth factor 1	Homo sapiens	26-31	
34256051-11	2021	CONCLUSIONS: There is a significant difference between BA and CA in evaluating IGF-1 levels in children, which can significantly reduce the proportion of IGF-1 values above the upper limit of the kit reference range in children.	Barium	55-57	insulin like growth factor 1	Homo sapiens	79-84	
34256051-11	2021	CONCLUSIONS: There is a significant difference between BA and CA in evaluating IGF-1 levels in children, which can significantly reduce the proportion of IGF-1 values above the upper limit of the kit reference range in children.	Barium	55-57	insulin like growth factor 1	Homo sapiens	154-159	
34256051-12	2021	This suggests that children with BA advanced in pubertal period, the evaluating results of IGF-1 should be corrected by using BA.	Barium	33-35	insulin like growth factor 1	Homo sapiens	91-96	
34256051-12	2021	This suggests that children with BA advanced in pubertal period, the evaluating results of IGF-1 should be corrected by using BA.	Barium	126-128	insulin like growth factor 1	Homo sapiens	91-96	
32727432-17	2020	Age-specific serum IGF-1 SDS and DHEAS SDS were risk factors for BA advancement independent of BMI.	Barium	65-67	insulin like growth factor 1	Homo sapiens	19-24